Re-induction of avelumab for patients with metastatic merkel cell carcinoma
Saved in:
Main Authors: | Goto Hiroyuki (Author), Yoshida Yuichi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma
by: Ping Hu, et al.
Published: (2024) -
Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
by: Bharmal M, et al.
Published: (2019) -
Merkel cell carcinoma in the context of follicular lymphoma treated with radiation and avelumab
by: Aya Nishizawa, MD, PhD, et al.
Published: (2024) -
Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response
by: Alexandra Picard‐Gauci, et al.
Published: (2022) -
Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma
by: Justin J. Wilkins, et al.
Published: (2019)